Armata Pharmaceuticals Inc. (ARMP) News, Price and Chart - FAWS

Your browser has either disabled or does not support javascript. Javascript is required for full website experience.

Fri October 16th, 2020

- 13:58
  AnalysisArmata's AP-PA02 Gets IND Clearance by FDA to Initiate StudyZacks

Thu October 15th, 2020

- 11:30
  Press ReleasesArmata Pharmaceuticals Announces Clearance of Investigational New Drug (IND) Application to Initiate Phase 1b/2a Clinical Trial of Lead Candidate AP-PA02 in Pseudomonas aeruginosa InfectionsPR Newswire

Tue September 29th, 2020

- 11:30
  Press ReleasesArmata Pharmaceuticals to Present at the Virtual 2020 World Antimicrobial Resistance CongressPR Newswire

Fri September 11th, 2020

- 11:30
  Press ReleasesArmata Pharmaceuticals Announces Participation in Upcoming Investor ConferencesPR Newswire

Thu August 13th, 2020

- 20:05
  Press ReleasesArmata Pharmaceuticals Announces Second Quarter 2020 Results and Provides General Corporate UpdatePR Newswire

SPY$344.390.7%

QQQ$285.470.59%

DOW$49.090.51%

ENBL$4.897.5%

JCP--

OGE$32.212.1%

RUN$60.43-3.1%

PSTH$24.63.8%

SPY$344.390.7%

QQQ$285.470.59%

DOW$49.090.51%

ENBL$4.897.5%

JCP--

OGE$32.212.1%

RUN$60.43-3.1%

PSTH$24.63.8%

About Developer Contact